Skip to main content
Elizabeth Griffiths, MD, Oncology, Buffalo, NY

ElizabethAGriffithsMD

Oncology Buffalo, NY

Hematologic Oncology

Associate Professor, Medicine, SUNY Buffalo School of Medicine & Biomedical

Dr. Griffiths is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Griffiths' full profile

Already have an account?

  • Office

    Elm and Carlton St
    Buffalo, NY 14263
    Phone+1 716-845-2300
    Fax+1 716-845-1322

Summary

  • Dr. Elizabeth Griffiths is a highly experienced oncologist specializing in hematologic oncology based in Buffalo, NY. She completed both her residency in Internal Medicine and fellowship in Hematology and Medical Oncology at Johns Hopkins University after graduating from the University of North Carolina at Chapel Hill School of Medicine. Her expertise extends to procedures such as bone marrow biopsy and managing platelet disorders, primary myelofibrosis, essential thrombocytosis, and aplastic anemia. Dr. Griffiths has carried out substantial research in her field, publishing numerous articles in esteemed journals like Cancer, Blood Advances, The Lancet Haematology, and Current Opinion in Hematology, and serves as the Principal Investigator for several clinical trials investigating treatments for Acute Myeloid Leukemia.

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2008
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2002 - 2005
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2002

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2005 - 2026
  • NY State Medical License
    NY State Medical License 2009 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Phase II Study of Oral Rigosertib Combined with Azacitidine (AZA) As First Line Therapy in Patients (Pts) with Higher-Risk Myelodysplastic Syndromes (HR-MDS)
    Elizabeth A. Griffiths, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • De Novo and Therapy-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome: Similarities and Differences in SNP-Array Detected Chromosomal Aberrations in Pre-Tran...
    Elizabeth A. Griffiths, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Results from a Global Randomized Phase 3 Study of Guadecitabine (G) Vs Treatment Choice (TC) in 815 Patients with Treatment Na¥ve (TN) AML Unfit for Intensive Chemothe...
    Elizabeth A. Griffiths, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Acute Myeloid Leukemia: Moving Beyond 7+3 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Acute Myeloid Leukemia: Moving Beyond 7+4 
    60th American Society of Hematology Annual Meeting - 12/1/2018
  • Long Term Results of a Randomized Phase 2 Dose-Response Study of Guadecitabine, a Novel Subcutaneous (SC) Hypomethylating Agent (HMA), in 102 Patients with Intermediat... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Roswell Park Hematologists Present New Research on FLT3 Inhibitors, CART-19 at ASH Annual Meeting
    Roswell Park Hematologists Present New Research on FLT3 Inhibitors, CART-19 at ASH Annual MeetingDecember 11th, 2021
  • First Advance in MDS for Decade: Luspatercept for Anemia
    First Advance in MDS for Decade: Luspatercept for AnemiaApril 6th, 2020

Professional Memberships